Bio Techne traded at $361.45 this Thursday August 18th, decreasing $1.32 or 0.36 percent since the previous trading session. Looking back, over the last four weeks, Bio Techne lost 3.20 percent. Over the last 12 months, its price fell by 24.05 percent. Looking ahead, we forecast Bio Techne to be priced at 369.02 by the end of this quarter and at 338.88 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 139.97 -2.32 -1.63% -16.52%
Becton, Dickinson and Co. 263.71 -0.52 -0.20% 5.78%
Bio-Rad Laboratories 519.57 -4.54 -0.87% -33.07%
Bruker 61.46 0.03 0.05% -26.61%
Charles River Laboratories 220.15 0.10 0.05% -47.62%
Catalent 106.31 -2.09 -1.93% -12.07%
Danaher 294.27 -3.00 -1.01% -8.48%
Enzo Biochem 2.59 -0.08 -3.00% -18.81%
Exact Sciences 38.48 -1.08 -2.73% -57.36%
Standard Biotools Inc 1.69 -0.12 -6.63% -74.12%
Hologic 71.58 -0.31 -0.43% -6.50%
Illumina 209.06 -3.96 -1.86% -55.55%
IQVIA Holdings Inc 238.82 -1.80 -0.75% -6.95%
Merck 182.00 -0.90 -0.49% -10.30%
Mettler Toledo International 1,358.72 2.12 0.16% -11.86%
NanoString Technologies 14.43 -0.20 -1.37% -71.87%
OraSure Technologies 4.32 0.02 0.47% -57.23%
Pacific Biosciences Of California 7.17 -0.44 -5.78% -72.23%
PerkinElmer 148.17 -2.57 -1.70% -18.48%
Repligen 241.21 -7.29 -2.93% -7.07%
Bio Techne 361.45 -1.32 -0.36% -24.05%
Thermo Fisher Scientific 595.01 -1.03 -0.17% 7.21%
Waters 331.19 -4.23 -1.26% -18.20%

Indexes Price Day Year
USND 12965 27.22 0.21% -10.84%
US400 2620 20.18 0.78% -0.94%

Bio Techne
Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.